1. Home
  2. TIRX vs PULM Comparison

TIRX vs PULM Comparison

Compare TIRX & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TIAN RUIXIANG Holdings Ltd

TIRX

TIAN RUIXIANG Holdings Ltd

HOLD

Current Price

$0.08

Market Cap

8.2M

Sector

Finance

ML Signal

HOLD

Logo Pulmatrix Inc.

PULM

Pulmatrix Inc.

HOLD

Current Price

$2.93

Market Cap

9.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TIRX
PULM
Founded
2010
2003
Country
China
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2M
9.4M
IPO Year
2019
2013

Fundamental Metrics

Financial Performance
Metric
TIRX
PULM
Price
$0.08
$2.93
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
99.2M
12.4K
Earning Date
01-01-0001
06-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
46.18
EPS
N/A
N/A
Revenue
N/A
$7,910,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$134.88
P/E Ratio
N/A
N/A
Revenue Growth
N/A
5069.93
52 Week Low
$0.04
$2.15
52 Week High
$3.45
$9.37

Technical Indicators

Market Signals
Indicator
TIRX
PULM
Relative Strength Index (RSI) 41.76 56.43
Support Level $0.07 $2.25
Resistance Level $0.99 $2.96
Average True Range (ATR) 0.02 0.18
MACD 0.01 0.09
Stochastic Oscillator 30.60 55.59

Price Performance

Historical Comparison
TIRX
PULM

About TIRX TIAN RUIXIANG Holdings Ltd

Tian Ruixiang Holdings Ltd is an Insurance Brokerage firm. It distributes a wide range of insurance products, which are categorized into two groups; property and casualty insurance, such as commercial property insurance, liability insurance, accidental insurance, and automobile insurance; and other insurances, such as health insurance, life insurance, and miscellaneous insurances. It also generates a small amount of revenue from risk management services. The firm act on behalf of its customers seeking insurance coverage from insurance companies. It generates revenue from the provision of insurance brokerage services.

About PULM Pulmatrix Inc.

Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

Share on Social Networks: